RNAi Therapeutics

Pages

▼
Showing posts with label Omontys. Show all posts
Showing posts with label Omontys. Show all posts
Wednesday, September 3, 2014

Regado Shock Raises Questions for Oligonucleotide Therapeutics Field

›
Ave biotech investor, morituri te salutant. Last week, aptamer company Regado Biosciences imploded in a spectacular fashion after it h...
1 comment:
›
Home
View web version
Powered by Blogger.